Skip to content
Open access

Risk Factors for Stereoacuity Impairment in Intermittent Exotropia: Results from a Nationwide Korean Study.

Aug 2026 · Korean Journal of Ophthalmology · 0 citations · 19 references
Medicine

TL;DR

Anisometropia and fusion control are key predictors of stereoacuity in IXT, whereas prematurity and low birth weight have limited independent effects.

Abstract

Purpose To identify clinical factors associated with stereoacuity impairment in patients with intermittent exotropia (IXT), with an emphasis on perinatal, refractive, motor, and sensory parameters. Methods This nationwide cross-sectional study analyzed 5,385 Korean patients with IXT from the Korean Intermittent Exotropia Multicenter Study (KIEMS). Stereoacuity was assessed using Titmus and Randot stereotests, and patients were classified into good or poor stereoacuity groups. Multivariable logistic regression was performed to identify independent predictors, including anisometropia (≥1.5 D) and refined Worth 4 Dot (W4D) categories (fusion, suppression, diplopia). Results Among 3,723 patients with Titmus and 952 with Randot results, anisometropia ≥1.5 D was strongly associated with poor Titmus stereoacuity (OR=4.707, p=0.0002). Good distance and near fusion control were protective factors in the Titmus model. An initial surgical plan was also linked to better Titmus stereoacuity. No variables remained significant in the Randot model. Neither prematurity nor low birth weight was independently associated with stereoacuity after adjustment. Conclusions Anisometropia and fusion control are key predictors of stereoacuity in IXT, whereas prematurity and low birth weight have limited independent effects. Early detection and correction of anisometropia and preservation of fusion control should be prioritized to maintain binocular visual function.

Read PDF

Similar papers

Open access Aug 2026

Clinical Outcomes of Individualized Office-Based Vision Therapy for Intermittent Exotropia: A Retrospective Cohort Study

Office-based VT was associated with functional recovery in patients with IXT, with greater gains in those who received more therapy sessions and had better baseline binocular function, and Prospective, randomized trials are needed to confirm these findings.

Xinyuan Pan, Ziang Yin, Huina Zhang et al. · 0 citations
Review Open access Sep 2026

Clinical Features of Acquired Esotropia and Surgical Management in a Real-World Cohort of Myopic Patients.

In this large, real-world, clinically and radiographically characterized cohort of myopic patients, the incidence of special strabismus was low and there was no association between refraction and size of deviation.

M. Gilhooley, Omran Sarwani, Gillian Johnson et al. · 0 citations
Sep 2026

Evaluation of surgical outcomes and intervention threshold for small-angle acute acquired comitant esotropia.

Surgery for small-angle AACE is safe and effective and may serve as a viable option for patients with deviations as small as 10 PD and a base-out recovery point of at least 15 PD at both near and far, pending validation in larger prospective cohorts.

Shan-Hong Li, Yi-Lan Zhou, Run-Yi Shao et al. · 0 citations
Open access Sep 2026

Effects of Home-Based Antisuppression and Binocular Integration Training in Patients with Intermittent Exotropia: A Retrospective Study

Objective To evaluate the association between 6-month home-based antisuppression with binocular integration training with binocular sensory outcomes and the 2-year surgical rate in patients with intermittent exotropia (IXT). Methods In this retrospective cohort study, patients diagnosed with IXT were included and class...

Zi-Qing Ding, Yu-Lian Zhou, Jing-Rong Liu et al. · 0 citations
Aug 2026

Esotropia Induced by Optical Correction in Myopic Patients.

These patients benefit from bilateral medial rectus recession similar to those who have esotropia without optical correction, without carrying the risk of overcorrection without spectacles or contact lenses.

Heba M. Fouad, Ahmed Awadein · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.